Gayer Charles K bought BCRX
December 22, 2025 · Form 4 insider transaction
Gayer Charles K bought 10,091 shares of BioCryst Pharmaceuticals, Inc. at $5.04 per share, a transaction worth $50.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
10,091
Price
$5.04
Total value
$50.9K
InsiderGayer Charles K
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 22, 2025
Filing dateDecember 23, 2025
Shares owned after902,583
OwnershipDirect
10b5-1 planNo
AmendedNo